Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$983,114
-$434,617 QoQ
Shares Held
40,827
-19.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,334
of 2,820 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STONEBRIDGE CAPITAL MANAGEMENT INC holds $14,542,000 across 7 Drug Manufacturers - General names. PFE ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,615 | $7,267,351 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,790 | $1,772,015 | |
| 3 | AMGN |
Amgen Inc
|
4,736 | $1,715,000 | |
| 4 | NVS |
Novartis AG
|
8,032 | $1,258,775 | |
| 5 | PFE |
Pfizer Inc
This page
|
40,827 | $983,114 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,525 | $779,310 | |
| 7 | LLY |
ELI LILLY & Co
|
639 | $766,435 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $983,114 | 40,827 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,417,731 | 50,489 | Shares | Sole | 2026-04-14 | |
| 2025-06-30 | $1,564,910 | 64,559 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $1,700,795 | 67,119 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,909,072 | 71,959 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,149,200 | 74,264 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,087,447 | 74,605 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,074,590 | 74,760 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,255,782 | 78,353 | Shares | Sole | 2024-03-05 | |
| No filing history on record for this holder in this stock. | ||||||